<DOC>
	<DOCNO>NCT01839890</DOCNO>
	<brief_summary>Study objective evaluation safety efficacy 9 month combination treatment bare metal Stent plus Paclitaxel Eluting Balloon v bare metal stent ( conventional treatment ) patient acute myocardial infarction systolic time elevation le 12 hour evolution .</brief_summary>
	<brief_title>Paclitaxel Eluting Balloon St Elevation Myocardial Infarction</brief_title>
	<detailed_description>This multicenter , prospective , randomize , open study After permeabilization clinical event responsible artery insertion bare metal stent , patient randomize 1:1 ratio one follow treatment group : Group 1 : post-dilatation paclitaxel elute balloon ( Pantera Lux Â® ) Group 2 : post-dilatation Patients ( legal representative ) must sign consent randomization . After surgery , patient treat dual antiplatelet therapy ( aspirin plus clopidogrel ) least one month group 2 patient ; least 3 month also treat paclitaxel elute balloon ( group 1 ) . Aspirin prescribe indefinitely accord usual practice patient . Patients monitor 30 day surgery , 6 12 month , ninth month ( patient receive angiographic control ) . The primary efficacy endpoint late lumen loss ( PLT ) compare value surgery control angiography 9 month This study involve patient 18 year old systolic time elevation myocardial infarction , new leave bundle branch block posterior AMI ( ECG ) occur within 12 hour onset symptom treatment primary angioplasty . They include total 220 patient .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Patients age less 18 year . Acute myocardial infarction ( AMI ) within 12 hour evolution ( onset symptom ) systolic time elevation least 1 mm ( record two contiguous lead ) , new leave bundle branch block , true posterior infarction . Patients candidate primary angioplasty medical criterion Written inform consent accord International Conference Harmonization / Guide Clinical Practice local legislation , obtain study procedure . Diameter vascular coronary artery treat 2 mm 4 mm . Patients 90100 % stenosis . Patients refuse participate study Cardiogenic shock ( define systolic blood pressure le 80 mm Hg 30 minute need vasopressor intraaortic balloon counterpulsation ) Concomitant diseases associated life expectancy le one year Angiographic variable : Trunk unprotected Branching ( side branch great 2.5 mm ) Sinus tachycardia segment elevation myocardial infarction thrombosis secondary stent If one stent treat single segment ( overlap stent ) . Patient candidate surgical revascularization within 30 day Stenosis great 30 mm length ( correspond ball longer available ) Reference vessel diameter le 2.5 mm great 4 mm ( large ball ) More severe stenosis artery expect address next 9 month Women childbearing age , possibility pregnancy first year followup , nursing . Any clinical condition , opinion investigator , consider clinically significant participate study . Subjects participate study drug medical . Individuals show inability follow instruction help course study . Bleeding diathesis disorder gastrointestinal ulceration cerebral circulatory disorder , restrict use treatment platelet aggregation inhibitor anticoagulant . Patients ejection fraction &lt; 30 % ( know ) . Allergy hypersensitivity paclitaxel intolerance , compound structurally relate Butyryl trinhexyl citrate ( BTHC ) matrix administration . Severe allergy contrast medium . Coronary artery spasm absence significant stenosis . Cases indicate bypass surgery within 30 day infarction .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Paclitaxel</keyword>
	<keyword>stent</keyword>
	<keyword>Acute infarction</keyword>
	<keyword>Systolic time elevation</keyword>
</DOC>